Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. 2012

Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
Departamento de Anatomía Humana y Psicobiología, Facultad de Psicología, Universidad de Murcia, Campus Universitario de Espinardo, Spain.

Many adolescents often take ethanol (EtOH) in combination with 3,4-methylenedioxymethylamphetamine (MDMA). In the present work, we used a mouse model to study the effect of repeated pre-exposure during adolescence to EtOH (2 g/kg), MDMA (10 or 20 mg/kg) or EtOH + MDMA on the rewarding and reinstating effects of MDMA in the conditioned place preference (CPP) paradigm. Pre-exposure to EtOH, MDMA or both increased the rewarding effects of a low dose of MDMA (1.25 mg/kg). These pre-treatments did not affect the acquisition of the CPP induced by 5 mg/kg of MDMA. However, the CPP was more persistent in mice pre-exposed to both doses of MDMA or to EtOH + MDMA20. After extinction of the CPP induced by 5 mg/kg of MDMA, reinstatement was observed in all groups with a priming dose of 2.5 mg/kg of MDMA, in the groups pre-exposed to EtOH or MDMA alone with a priming dose of 1.25 mg/kg, and in the groups pre-treated with MDMA alone with a priming dose of 0.625 mg/kg. Pre-treatment during adolescence with MDMA or EtOH induced long-term changes in the level of biogenic amines [dihydroxyphenyl acetic acid, homovanillic acid, dopamine turnover, serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindole acetic acid (5-HIAA) in the striatum, and 5-HT and 5-HIAA in the cortex] after the first reinstatement test, although these effects depended on the dose used during conditioning. These results suggest that exposure to EtOH and MDMA during adolescence reinforces the addictive properties of MDMA.

UI MeSH Term Description Entries
D008297 Male Males
D002492 Central Nervous System Depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). CNS Depressants,Depressants, CNS
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001679 Biogenic Amines A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology. Amines, Biogenic,Biogenic Amine,Amine, Biogenic
D012201 Reward An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. Rewards

Related Publications

Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
July 2011, Physiology & behavior,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
October 2007, Pharmacology, biochemistry, and behavior,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
April 2015, Brain research bulletin,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
February 2010, Progress in neuro-psychopharmacology & biological psychiatry,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
May 2017, British journal of pharmacology,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
November 2011, Psychopharmacology,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
September 2009, Addiction biology,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
July 2020, Journal of psychopharmacology (Oxford, England),
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
August 2009, The international journal of neuropsychopharmacology,
Bruno Ribeiro Do Couto, and Manuel Daza-Losada, and Marta Rodríguez-Arias, and Roser Nadal, and Consuelo Guerri, and Teresa Summavielle, and Jose Miñarro, and Maria A Aguilar
November 2014, Behavioural brain research,
Copied contents to your clipboard!